Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Assay-Dependent Potency IC 50 values require test conditions A value of approximately 1.2 M is commonly reported for NNMT inhibition under a specified in-vitro enzyme assay using defined substrate and SAM concentrations
A skeptical clinician would note that without bioequivalence data, assumed equivalence to the Phase 3 trials is an extrapolation
AOD-9604 has substantial Phase 1, 2, and IIb research from Metabolic Pharmaceuticals' development program
Most researchers choose between two common approaches
If your schedule is urgent or you are close to running out, contact a healthcare professional rather than relying on shipping timing to start or continue treatment
